Marsh; David A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Marsh; David A..The latest application filed is for "time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation".

Company Profile

1.5.8

Marsh; David A. - Irvine CA
Marsh; David A. - Fort Worth TX
Marsh; David A. - Rochester NY
Marsh; David A. - Shrewsbury MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Time Released Biodegradable Or Bioerodible Microspheres Or Microparticles Suspended In A Solidifying Depot-forming Injectable Drug Formulation App 20200297650 - Marsh; David A. ; et al.	2020-09-24
Autoclavable Suspensions Of Cyclosporin A Form 2 App 20180207230 - Blanda; Wendy M. ; et al.	2018-07-26
Autoclavable suspensions of cyclosporin A Form 2 Grant 9,919,028 - Blanda , et al. March 20, 2	2018-03-20
Autoclavable Suspensions Of Cyclosporin A Form 2 App 20160271207 - Blanda; Wendy M. ; et al.	2016-09-22
Time Released Biodegradable Or Bioerodible Microspheres Or Microparticles Suspended In A Solidifying Depot-forming Injectable Drug Formulation App 20130189369 - Marsh; David A. ; et al.	2013-07-25
Autoclavable Suspensions Of Cyclosporin A Form 2 App 20130123194 - Blanda; Wendy M. ; et al.	2013-05-16
Peri-corneal Drug Delivery Device App 20100226962 - Rodstrom; Theron R. ; et al.	2010-09-09
Ophthalmic injector App 20070060887 - Marsh; David A. ; et al.	2007-03-15
Method for indicating neutralization of contact lens disinfecting solutions Grant 5,603,897 - Heiler , et al. February 18, 1	1997-02-18
Cleaning hydrophilic contact lenses by electrochemical means Grant 5,451,303 - Heiler , et al. September 19, 1	1995-09-19
Method and composition for cleaning contact lenses with cyclodextrins Grant 5,364,637 - De , et al. November 15, 1	1994-11-15
Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis Grant 4,235,893 - Brodie , et al. November 25, 1	1980-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.